Figure 3
Figure 3. Quantitative trait locus (QTL) mapping for survival and WBC count in leukemic PR+ F2 mice. QTL and survival curves were generated from analysis of F2 mice. (A) Survival QTL (Mleu1.1) in the treated model on chromosome 1 at 42.8 cM that is significant at the genomewide level. (B) Survival of ENU-treated F2 mice is significantly (P < .001) affected by genotype at Mleu1.1. Arrows indicate ENU treatment at 9 and 10 weeks of age. (C) WBC count QTL (Wbc19.1) on chromosome 19 at 47.0 cM that is significant in the covariate model at the chromosome-wide level. (D) At Wbc19.1, SWR/J homozygotes have a higher mean WBC count than B6C3F1 homozygotes (79 ± 128 vs 48 ± 96, respectively, P < .01) independent of treatment status. Data are plotted as median (horizontal bar), 25th to 75th percentile (box) and range (whiskers).

Quantitative trait locus (QTL) mapping for survival and WBC count in leukemic PR+ F2 mice. QTL and survival curves were generated from analysis of F2 mice. (A) Survival QTL (Mleu1.1) in the treated model on chromosome 1 at 42.8 cM that is significant at the genomewide level. (B) Survival of ENU-treated F2 mice is significantly (P < .001) affected by genotype at Mleu1.1. Arrows indicate ENU treatment at 9 and 10 weeks of age. (C) WBC count QTL (Wbc19.1) on chromosome 19 at 47.0 cM that is significant in the covariate model at the chromosome-wide level. (D) At Wbc19.1, SWR/J homozygotes have a higher mean WBC count than B6C3F1 homozygotes (79 ± 128 vs 48 ± 96, respectively, P < .01) independent of treatment status. Data are plotted as median (horizontal bar), 25th to 75th percentile (box) and range (whiskers).

Close Modal

or Create an Account

Close Modal
Close Modal